Drug makers aren’t backing down despite another district court ruling Monday (April 29) against their efforts to delay Medicare drug price negotiation, with Bristol Myers Squibb and Johnson & Johnson swiftly appealing Monday’s rulings in New Jersey, AstraZeneca the same day appealing a recent ruling against it in Delaware, and the drug lobby PhRMA and allied associations set to make a pitch in oral arguments Wednesday (May 1) for the 5th Circuit to revive a case recently dismissed by a...